Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 4, 2006
CC chemokine receptor expression in childhood asthma is influenced by natural allergen exposurePeroni G Diego, Panina Bordignon Paola, Piacentini L Giorgio, et al.
AIDS (London, England)|November 21, 2002
Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptionsBecky Schweighardt, Gabriel M Ortiz, Robert M Grant, et al.
AIDS Research and Human Retroviruses|May 31, 2002
Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected personsJohn A Bartlett, G Diego Miralles, Anne D Sevin, et al.
AIDS (London, England)|January 28, 2006
Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjectsMelanie Thompson, Edwin DeJesus, Gary Richmond, et al.
The Review of Scientific Instruments|August 4, 2023
Graphite resistive heated diamond anvil cell for simultaneous high-pressure and high-temperature diffraction experimentsHuijeong Hwang, Yoonah Bang, Jinhyuk Choi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infectionThomas H Alexander, Gabriel M Ortiz, Melissa F Wellons, et al.
The Journal of Infectious Diseases|March 5, 2004
Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIVJoseph J Eron, Roy M Gulick, John A Bartlett, et al.
The Journal of Infectious Diseases|March 5, 2005
T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimenJacob P Lalezari, Nicholaos C Bellos, Kunthavi Sathasivam, et al.
Minerva Cardioangiologica|January 21, 2015
The TITAN-AMI multicenter registry evaluating the usage of Titan2 stent in patients with ST segment elevation myocardial infarction. Final result at 12-month follow-upJ A Gómez-Hospital, J Mauri, E Pinar, et al.
Histopathology|July 30, 2024
Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literatureAnandi Lobo, Katrina Collins, Seema Kaushal, et al.
Pageof 2